Glaxo Sells Drug Rights to Novartis

GlaxoSmithKline is selling its remaining rights to a drug used in treating autoimmune diseases to Novartis for up to $1 billion, plus royalties.

from WSJ.com: US Business http://ift.tt/1JaRfXO
via IFTTT